SOURCE-LINKED INTELLIGENCE

Development and validation of a framework using multiple sources of real-world data to assess the benefit-risk balance of advanced therapies in inflammatory bowel disease

CORDIS · observation · Publication date unknown

clinicians, whose impact will be assessed by a pragmatic RCT nested in nationwide healthcare databases. This challenging project will involve multi-disciplinary aspects, from qualitative approach to artificial intelligence, to clarify the position of each treatment in IBD and disseminate findings to patients and clinicians. Besides scientific importance, it will have societal impact by setting the stage for a novel post-marketing drug surveillance framework applicable not only to future IBD treatments but also to other chronic diseases. pharmacoepidemiology; gastroenterology; inflammatory bowel diseases; administrative health databases

Read original source ↗ Open in workspace

recordType

award

status

SIGNED

region

EU

value

1473454

unit

EUR